Situs Slot Gacor

American jury awarded $ 2 billion injury in Roundup weedkiller cancer claims

  File recording taken July 9, 2018, shows an employee who places Roundup products on a shelf at a store in San Rafael, California Image copyright


Bayer bought Roundup as part of the takeover of the US company Monsanto

A jury in California has awarded more than $ 2 billion to a couple who said that weedkiller Roundup was responsible for cancer.

It is the third time that the German pharmaceutical group Bayer has been ordered to pay damages over its glyphosate-based herbicide.

The jury considered that the company had acted negligently and did not warn about the risks associated with the product.

Bayer denied the allegations. It insists that Roundup is safe to use.

The company bought the product last year as part of a $ 66 billion acquisition of US rival Monsanto.

On Monday, a jury in Oakland, California, considered for plaintiffs Alva and Alberta Pilliod contracted non-Hodgkin's lymphoma.

Attorneys for the couple, who are in the 70's, described the replacement award as "historic".

"The jury envisioned internal corporate documents showing that from day Monsanto has never had any interest in finding out if Roundup is safe, their advice, Brent Wisner, says.

In a statement, Bayer said it was disappointed with the verdict and would appeal.

It called the jury's decision "excessive and unjustified" and added that both Alva and Alberta Pilliod had stories about diseases that were known risk factors for non-Hodgkin's lymphoma.

The company insists that decades of studies have shown glyphosate and Roundup to be safe for human use. and has become one of the most widely used ingredients in the mining industry around the world.

But Bayer faces more than 1[ads1]3,400 US lawsuits over Roundup's alleged cancer risk. illions to another Californian man after finding out that Roundup had caused cancer.

In August, another Californian man was awarded $ 289 million after a jury also found Roundup caused his cancer.

Source link

Back to top button